Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Céline Fugere"'
Autor:
Angela Tata, Garvin Dodard, Céline Fugère, Corinne Leget, Mélody Ors, Benjamin Rossi, Eric Vivier, Laurent Brossay
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Checkpoint blockade therapy is effective against many cancers; however, new targets need to be identified to treat patients who do not respond to current treatment or demonstrate immune escape. Here, we showed that blocking the inhibitory receptor Ki
Externí odkaz:
https://doaj.org/article/8c7affb039e944c0820ccf980b4ec0be
Autor:
S. M. Shahjahan Miah, Chathuraka T. Jayasuriya, Alexander I. Salter, Emma C. Reilly, Céline Fugere, Wentian Yang, Qian Chen, Laurent Brossay
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The ubiquitously expressed tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 (SHP-2, encoded by Ptpn11) is required for constitutive cellular processes including proliferation, differentiation, and the regulation of immune re
Externí odkaz:
https://doaj.org/article/50a394ed81284e4b95a06f6f2878920e
Autor:
Garvin Dodard, Céline Fugere, Corinne Leget, Benjamin Rossi, Angela Tata, Mélody Ors, Eric Vivier, Laurent Brossay
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1933808. ⟨10.1080/2162402X.2021.1933808⟩
OncoImmunology, 2021, 10 (1), pp.1933808. ⟨10.1080/2162402X.2021.1933808⟩
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1933808. ⟨10.1080/2162402X.2021.1933808⟩
OncoImmunology, 2021, 10 (1), pp.1933808. ⟨10.1080/2162402X.2021.1933808⟩
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Checkpoint blockade therapy is effective against many cancers; however, new targets need to be identified to treat patients who do not respond to current treatment or demonstrate immune escape. Here, we showed that blocking the inhibitory receptor Ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f90a68051f20843e6a2393817d6d185
https://hal-amu.archives-ouvertes.fr/hal-03375341
https://hal-amu.archives-ouvertes.fr/hal-03375341
Autor:
Céline Fugere, Wentian Yang, Chathuraka T. Jayasuriya, Alexander I. Salter, Emma C. Reilly, Qian Chen, S. M. Shahjahan Miah, Laurent Brossay
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology
Frontiers in Immunology
The ubiquitously expressed tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 (SHP-2, encoded by Ptpn11) is required for constitutive cellular processes including proliferation, differentiation, and the regulation of immune re
Publikováno v:
Blood. 114:5299-5306
KLRG1 is an inhibitory receptor expressed on a subset of mature T and NK cells. Recently, E-, N-, and R-cadherin have been identified as ligands for KLRG1. Cadherins are a large family of transmembrane or membrane-associated glycoproteins that were t
Autor:
Marlowe S. Tessmer, Frederik Stevenaert, H. Jonathan Chong, Laurent Brossay, Olga V. Naidenko, Georges Leclercq, Céline Fugere
Publikováno v:
International Immunology. 19:391-400
The killer cell lectin-like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as subsets of T cells in naive mice. In vivo, pathogenic immune system activation induces dramatic
Autor:
Neetu Srivastava, Alexander I. Salter, Laurent Brossay, Emma C. Reilly, Céline Fugere, Courtney K. Anderson, William G. Kerr, Leon Toussaint
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 195(5)
SH2-containing inositol phosphatase-1 (SHIP1) is a 5' inositol phosphatase known to negatively regulate the signaling product of the phosphoinositide-3 kinase (PI3K) pathway, phosphatidylinositol (3,4,5)-trisphosphate (PIP3). SHIP1 is recruited to a
Publikováno v:
The FASEB Journal. 22:398-398